Skip to main content
. 2013 Nov 15;14(11):22558–22603. doi: 10.3390/ijms141122558

Table 5.

Antipsychotic and tetrabenazine neuroprotective effects in Huntington’s disease models.

Neuroprotective action D2 antagonist antipsychotics Trifluoperazine Haloperidol Loxapine Tetrabenazine
Huntingtin clearance + +
AP-1 DNA binding
Histone acetylation
p53
MiR-222
Mitochondria + + +
Apoptosis + +
Neurogenesis
BDNF
Striatal preservation + +
Cognitive integrity
Motor integrity +
Delay of disease onset
Enhanced survival